Unio Capital’s Bristol-Myers Squibb BMY Stock Holding History

Unio Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-5,880	Closed	-$281K	–	65
2019 Q1	$281K	Sell	5,880 -325	-5%	-$16.2K	0.2%	56
2018 Q4	$323K	Sell	6,205 -1,800	-22%	-$96.7K	0.25%	47
2018 Q3	$497K	Sell	8,005 -725	-8%	-$43K	0.33%	41
2018 Q2	$483K	Sell	8,730 -815	-9%	-$44K	0.36%	39
2018 Q1	$604K	Sell	9,545 -100	-1%	-$6.43K	0.5%	31
2017 Q4	$591K	Buy	+9,645	New	+$603K	0.49%	39

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Unio Capital's BMY Position: Q2 2019 in Review

Unio Capital sold out of Bristol-Myers Squibb (BMY) in Q2 2019, closing a stake of 5,880 shares — an estimated $281K sold.

Unio Capital first reported a position in BMY in Q4 2017 and held it in 6 quarters. The position peaked at $604K in Q1 2018. 1,777 funds tracked by Wall St. Rank hold BMY as of Q2 2019.

Unio Capital reported no remaining Bristol-Myers Squibb position as of Q2 2019 after selling out during the quarter.
Unio Capital sold 5,880 Bristol-Myers Squibb shares in Q2 2019, an estimated $281K.
Unio Capital first reported a position in Bristol-Myers Squibb in Q4 2017 and held it in 6 quarters.
Unio Capital's Bristol-Myers Squibb position peaked at $604K in Q1 2018.
1,777 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2019.

Based on Unio Capital's 13F filing for Q2 2019, filed 14 Aug 2019.